Literature DB >> 22731642

Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.

Neha Singh1, Himanshu Rai, Nakul Sinha, Sudeep Kumar, Chandra M Pandey, Suraksha Agrawal.   

Abstract

AIM: Monocytes play a critical role in atherosclerosis. CX3CR1 is expressed on monocytes and acts as either a monocyte chemokine receptor or an adhesion molecule. Two common variants of CX3CR1, V249I and T280M, reportedly decrease the coronary artery risk.
RESULTS: We have examined the CX3CR1 genotype in 152 early-onset coronary artery disease (CAD) patients (age ≤ 45 years) and in 156 late-onset CAD patients (age ≥ 55 years) and in 300 healthy controls. Homozygous alleles CX3CR1-V249 and T280 were found associated with early onset of CAD (odds ratio [OR] 2.7, p<0.0001 and OR 2.76, p<0.0001, respectively), while alleles CX3CR1-I249 and M280 were found to be protective against early onset of disease (OR 0.36, p<0.0001 and OR 0.35, p<0.0001, respectively). A significant protective effect of the I(249)M(280) haplotype was observed in the early-onset CAD population (OR=0.40, 95% confidence interval [CI]=0.19-0.86, p=0.02), while the haplotype V(249)T(280) was associated with early onset of disease (OR=1.53, 95% CI=1.05-2.23, p=0.02). OBSERVATION: It might be possible that the risk of early onset of CAD is associated with a genetic variation in chemokine receptor CX3CR1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22731642     DOI: 10.1089/gtmb.2011.0256

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  4 in total

1.  [Association between CMTM5 gene and coronary artery disease and the relative mechanism].

Authors:  T F Liu; T Lin; L H Ren; G P Li; J J Peng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

2.  Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.

Authors:  Jian Wu; Rui-Xing Yin; Quan-Zhen Lin; Tao Guo; Guang-Yuan Shi; Jia-Qi Sun; Shao-Wen Shen; Qing Li
Journal:  Dis Markers       Date:  2014-08-26       Impact factor: 3.434

3.  CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients.

Authors:  Asmaa Fathelbab Ibrahim; Asmaa Osama Bakr Seddik Osman; Lamiaa M Elabbasy; Mostafa Abdelsalam; A M Wahab; Maysaa El Sayed Zaki; Radwa Ahmed Rabea Abdel-Latif
Journal:  Int J Nephrol       Date:  2021-04-24

4.  Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.

Authors:  A K Yadav; V Kumar; V Jha
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.